Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Hugosson

Showing results (21-30 of 201) with videos related to

Pageof 21
Sort By:
Annals of Internal Medicine|April 5, 2012
Screening for prostate cancerSigrid Carlsson, Andrew Vickers, Hans Lilja, et al.
American Journal of Men'S Health|June 23, 2025
Prostate Cancer Screening Decisions: Which Aspects Do Men Value Most? An Interview Study With Men Invited to a Population-Based ProgramLinda Svensson, Ola Bratt, Jonas Hugosson, et al.
The Lancet. Oncology|March 9, 2017
The drama of prostate cancer diagnosticsOla Bratt, Jonas Hugosson, Laurence Klotz, et al.
European Urology|June 26, 2025
Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GÖTEBORG-1 TrialEmmeli Palmstedt, Marianne Månsson, Jonas Hugosson, et al.
European Urology|July 8, 2015
Corrigendum to "Incidence of Prostate Cancer After Termination of Screening in a Population-based Randomised Screening Trial" [Eur Urol 2013;64:703-9]Anna Grenabo Bergdahl, Erik Holmberg, Sue Moss, et al.
Scandinavian Journal of Urology and Nephrology|October 25, 2008
Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomyAli Khatami, Jonas Hugosson, Wanzhong Wang, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 26, 2019
Is leisure time sitting associated with mortality rates among men diagnosed with localized prostate cancer?Stephanie E Bonn, Erik Holmberg, Jonas Hugosson, et al.
Cancer|October 9, 2009
Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendeesAnna Grenabo Bergdahl, Gunnar Aus, Hans Lilja, et al.
European Urology|June 1, 2013
Incidence of prostate cancer after termination of screening in a population-based randomised screening trialAnna Grenabo Bergdahl, Erik Holmberg, Sue Moss, et al.
European Urology|August 29, 2006
Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer--results from a prospective, population-based randomized controlled trialGunnar Aus, Svante Bergdahl, Pär Lodding, et al.
Pageof 21

Showing results (21-30 of 201) with videos related to

Sort By:
Pageof 21
Annals of Internal Medicine|April 5, 2012
Screening for prostate cancerSigrid Carlsson, Andrew Vickers, Hans Lilja, et al.
American Journal of Men'S Health|June 23, 2025
Prostate Cancer Screening Decisions: Which Aspects Do Men Value Most? An Interview Study With Men Invited to a Population-Based ProgramLinda Svensson, Ola Bratt, Jonas Hugosson, et al.
The Lancet. Oncology|March 9, 2017
The drama of prostate cancer diagnosticsOla Bratt, Jonas Hugosson, Laurence Klotz, et al.
European Urology|June 26, 2025
Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GÖTEBORG-1 TrialEmmeli Palmstedt, Marianne Månsson, Jonas Hugosson, et al.
European Urology|July 8, 2015
Corrigendum to "Incidence of Prostate Cancer After Termination of Screening in a Population-based Randomised Screening Trial" [Eur Urol 2013;64:703-9]Anna Grenabo Bergdahl, Erik Holmberg, Sue Moss, et al.
Scandinavian Journal of Urology and Nephrology|October 25, 2008
Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomyAli Khatami, Jonas Hugosson, Wanzhong Wang, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 26, 2019
Is leisure time sitting associated with mortality rates among men diagnosed with localized prostate cancer?Stephanie E Bonn, Erik Holmberg, Jonas Hugosson, et al.
Cancer|October 9, 2009
Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendeesAnna Grenabo Bergdahl, Gunnar Aus, Hans Lilja, et al.
European Urology|June 1, 2013
Incidence of prostate cancer after termination of screening in a population-based randomised screening trialAnna Grenabo Bergdahl, Erik Holmberg, Sue Moss, et al.
European Urology|August 29, 2006
Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer--results from a prospective, population-based randomized controlled trialGunnar Aus, Svante Bergdahl, Pär Lodding, et al.
Pageof 21